Study: Popular GLP-1 Drug May Slow Down Biological Aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases
People turn to NAD+ therapy (often via IV or injection) for: We offer NAD+ as part of our anti-aging and IV therapy menu, frequently alongside peptide protocols for people focused on longevity
This translated to a loss of 22.8 kg in the tirzepatide-treated patients versus 15.0 kg in those who received semaglutide
If you are experiencing significant gastrointestinal discomfort, your healthcare provider may suggest switching your injection site to the thigh to see if it provides relief
Weight management and obesity Injectable semaglutide 2.4 mg (Wegovy) is approved for chronic weight management in adults with a BMI of 30 kg/m or higher, or in adults with a BMI of 27 kg/m or higher who also have a weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol